Fortress Biotech Inc Earnings
The next earnings date for Fortress Biotech Inc is August 13, 2026.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Fortress Biotech Inc Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Fortress Biotech Inc Earnings: Historical
| 11/14/2025 | --- | $0.11 | 1,200.00% |
| 08/14/2025 | --- | $0.45 | 542.86% |
| 05/15/2025 | --- | $-0.48 | -9.09% |
| 03/26/2025 | Before Market | $-0.30 | 60.09% |
| 08/13/2024 | After Market | $-0.73 | 40.16% |
| 05/15/2024 | After Market | $-1.03 | 40.46% |
| 03/28/2024 | After Market | $-1.28 | 35.03% |
| 11/14/2023 | After Market | $-0.94 | 70.72% |
| 08/14/2023 | After Market | $-0.24 | -4.35% |
| 05/15/2023 | After Market | $-0.21 | -5.00% |
More About Fortress Biotech Inc
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Amzeeq, a minocycline topical foam for the treatment of lesions of non-nodular moderate to severe acne vulgaris; Zilxi, a minocycline topical foam for the treatment of lesions of rosacea; Exelderm, an antifungal cream for topical use; Targadox, an oral doxycycline drug for the therapy of severe acne; Luxamend, a water-based emulsion for the treatment of superficial wounds, minor cuts or scrapes, dermal ulcers, donor sites, first and second-degree burns, and radiation dermatitis; and UNLOXCYT, a death-ligand 1 blocking antibody for the treatment of metastatic cutaneous squamous cell carcinoma. It also develops CUTX-101, a copper histidinate injection, which is in FDA approved stage for the treatment of Menkes disease; IV Tramadol, an intravenous formulation, which is in NDA/BLA filed stage for the treatment of post-operative acute pain; Dotinurad, a urate transporter inhibitor, which is in Phase III for the treatment of gout and chronic kidney diseases; CAEL-101, a light chain fibril-reactive monoclonal antibody, which is in Phase III for the treatment of amyloid light chain amyloidosis; and Triplex, a universal recombinant modified vaccinia ankara viral vector vaccine, which is in Phase II for the treatment of cytomegalovirus, anti-human immunodeficiency virus, non-hodgkin lymphoma, and acute lymphoblastic leukemia. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.
“Fortress Biotech Inc Earnings” Can Refer to the Fortress Biotech Inc Earnings Date
Some people say “Fortress Biotech Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Fortress Biotech Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Fortress Biotech Inc Stock on the Earnings Date
If you own Fortress Biotech Inc stock (FBIO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Fortress Biotech Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Fortress Biotech Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Fortress Biotech Inc Earnings
You can contact us any time if you would like to ask questions about Fortress Biotech Inc earnings or anything else related to the stock market.